Physician profile
Kyle Allen
NPI 1760993513
$752.19
in general payments reported to CMS, 2019-2025
14 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.45 · 2024: $297 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $236.78 | 2024-2025 | Talvey, Carvykti, Erleada |
| Novartis Pharmaceuticals Corporation | $120.63 | 2023-2025 | |
| Glaxosmithkline, LLC. | $119.04 | 2025 | Ojjaara |
| Daiichi Sankyo INC. | $49.88 | 2024-2025 | Enhertu |
| Genzyme Corporation | $44.26 | 2024 | |
| Incyte Corporation | $25.83 | 2025 | Zynyz, Monjuvi |
| Coherus Oncology, INC. | $25.33 | 2024 | |
| Adaptive Biotechnologies Corporation | $25.05 | 2025 | Clonoseq |
| Apellis Pharmaceuticals, INC. | $21.36 | 2025 | Empaveli |
| Ipsen Biopharmaceuticals, INC | $18.98 | 2024 | Onivyde, Somatuline Depot |
| Regeneron Healthcare Solutions, INC. | $18.16 | 2025 | Lynozyfic |
| Pfizer INC. | $17.03 | 2024 | |
| Lilly USA, LLC | $15.86 | 2025 | Jaypirca, Verzenio |
| Astrazeneca Pharmaceuticals LP | $14.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.